Sachleben Mark 4

What Happened

• Mark Sachleben, a director of Acuity Inc. (AYI), was granted 546 Deferred Restricted Stock Units (DSUs) on January 21, 2026. The grant is recorded as a derivative award (code A) with an acquisition price of $0.00. Using the issuer's valuation method (see footnote), the DSUs equal roughly $175,042 (546 × $320.59 average price).

Key Details

• Transaction date: 2026-01-21; Form 4 filed: 2026-01-23.
• Award type: Deferred Restricted Stock Units (DSUs); reported as a derivative grant (A).
• Shares/units granted: 546 DSUs; acquisition price: $0.00.
• Valuation: Footnote states DSU count/value was based on $320.59 (average high/low over five trading days), yielding ≈ $175,042.
• Vesting/payment: DSUs vest in full on the first anniversary of the grant date (or earlier at the next annual meeting) and are payable upon retirement either as a lump sum or in five annual installments (per footnote).
• Source: DSUs resulted from the director electing to receive part of annual director fees in DSUs (routine compensation).
• Shares owned after transaction: not specified in this Form 4.
• Filing timeliness: Filed two days after the grant date (within the usual Form 4 reporting window); no late-filing indication.

Context

• These DSUs are compensation-related and are a deferred, not immediate, transfer of common stock — they do not represent an open-market purchase or sale. Such grants are routine for directors who elect deferred pay and do not necessarily signal a buy/sell decision on the director's part.